A Multicenter Registry to Study the Characteristics and Outcomes of Jordanian Heart Failure Patients.

Heart Failure Clinical Trial

— JoHFR  

Official title:

The Jordanian Heart Failure Registry (JoHFR)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04829591
• Other study ID #: JoCVRG
• Status: Recruiting
• Start date: July 1, 2021
• Est. completion date: December 30, 2024

Study information

• Verified date: April 2022
• Source: Jordan Cardio Vascular Research Group
• Contact: Hadi M Abu-Hantash, MD, MSc
• Phone: +962796721818
• Email: drhadi57[@]hotmail.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Heart Failure research registry is a collection of computerized information about individuals with heart failure. The database in this registry is obtained from several Jordanian medical centers which will represent an extremely valuable resource for epidemiological research on heart failure patients.

Description:

Understanding the cause of Heart Failure (HF) and how the body will respond to it, is critical for an effective treatment. HF is a global problem with significant morbidity and mortality, despite improved understanding of the pathophysiology and a growing range of therapeutic options. Jordanian Heart Failure Registry (JoHFR) will be the first research project of heart failure prevalence in Jordan. It is undertaken by primary healthcare professionals with main aim to improve knowledge about the care of patients with HF. The investigators responsible for conducting this research are physicians and their teams who deal with heart failure patients in their outpatient and inpatient clinic centers including the public and private medical sectors in Jordan's medical community. Standards in the Hashemite kingdom of Jordan complies with the recognized good guideline directed medical practices internationally

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 4000
• Est. completion date: December 30, 2024
• Est. primary completion date: December 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

1. Patients who are 18 years or older with Heart Failure diagnosis as defined by internationally recognized guidelines.

2. Current residents of the Hashemite Kingdom of Jordan

Exclusion Criteria:

1. Patients who refuse or unable to sign a consent form.

2. Patient inability to follow up with provider

Related Conditions & MeSH terms

• Acute Heart Failure
• Chronic Heart Failure
• Heart Failure

Intervention

Other:
• observational
Heart failure, non interventional

Locations

Country	Name	City	State
Jordan	Farah Medical Campus	Amman

Sponsors (1)

Lead Sponsor	Collaborator
Jordan Cardio Vascular Research Group

Country where clinical trial is conducted

Jordan, 

References & Publications (4)

Bergethon KE, Ju C, DeVore AD, Hardy NC, Fonarow GC, Yancy CW, Heidenreich PA, Bhatt DL, Peterson ED, Hernandez AF. Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry. Circ Heart Fail. 2016 Jun;9(6). pii: e002594. doi: 10.1161/CIRCHEARTFAILURE.115.002594. — View Citation

Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, Ferrari R, Piepoli MF, Delgado Jimenez JF, Metra M, Fonseca C, Hradec J, Amir O, Logeart D, Dahlström U, Merkely B, Drozdz J, Goncalvesova E, Hassanein M, Chioncel O, Lainscak M, Seferovic PM, Tousoulis D, Kavoliuniene A, Fruhwald F, Fazlibegovic E, Temizhan A, Gatzov P, Erglis A, Laroche C, Mebazaa A; Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016 Jun;18(6):613-25. doi: 10.1002/ejhf.566. Erratum in: Eur J Heart Fail. 2017 Mar;19(3):438. — View Citation

Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, Gomez-Mesa JE, Leong D, Ezekowitz J, Hage C, Lanas F, Maggioni AP, Sliwa K, Zhu J, Rouleau J, Balasubramanian K, Yusuf S; G-CHF Investigators. A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. Am Heart J. 2020 Sep;227:56-63. doi: 10.1016/j.ahj.2020.06.002. Epub 2020 Jun 6. — View Citation

Savarese G, Vasko P, Jonsson Å, Edner M, Dahlström U, Lund LH. The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure. Ups J Med Sci. 2019 Jan;124(1):65-69. doi: 10.1080/03009734.2018.1490831. Epub 2018 Aug 9. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Cardiovascular death	The main objective of the JoHFR is to obtain reliable estimate of rates of cardiovascular death and or hospitalization for decompensated heart failure	12 months
Secondary	worsening kidney function	as compared to baseline eGFR	12 months